Skip to main content
SpringerLink
Log in

Cerebral blood flow in patients with dementia of Alzheimer’s type

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

In the normal brain as well as in Alzheimer’s disease (AD), regional cerebral blood flow (CBF) is coupled to metabolic demand and, therefore, changes in CBF reflect variations in neuronal metabolism. The use of radionuclide techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), provides an accurate assessment of regional functional activity, i.e., CBF and metabolism, and could be very helpful for the differential diagnosis of AD. This disease is characterized by a decrease in global CBF and metabolism. When found, a symmetric bi-parieto-temporal CBF reduction is highly diagnostic for AD, despite the fact that a similar CBF pattern could also be observed in other types of dementia. Many AD patients with parieto-temporal flow reduction also have a diffuse flow reduction in the frontal cortical areas, particularly in advanced stages of the disease. Lateral CBF asymmetry is also very frequent; speech disorders are highly characteristic of left-sided flow reduction, while visuospatial apraxia is dominating in the right-sided cases. In advanced and severe cases of AD, CBF and metabolism tend to be more uniformly reduced throughout the cortex, sparing only the primary visual and sensory-motor cortices. PET and SPECT measurement of brain perfusion and metabolism has added a new dimension to the knowledge of dementia disorders, with a better differential diagnosis between AD and other forms of dementia. The correlation with neuropsychological data has also given new insight into the disease. (Aging Clin. Exp. Res. 5: 19–26, 1993)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hafner H.: The brain disease of aging. Epidemiology and risk factors of senile dementia (Alzheimer). In: Beyreuther K., Schettler G. (Eds.), Molecular mechanisms of aging. Springer Verlag, Heidelberg, 1990, pp. 2–17.

    Chapter  Google Scholar 

  2. McKahn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944, 1984.

    Article  Google Scholar 

  3. Johnson K.A., Davis K.R., Buonanno F.S., Brady T.J., Rosen J., Growdon J.H.: Comparison of Magnetic Resonance and Roengten Ray Computed Tomography in Dementia. Arch. Neurol. 44: 1075–1080, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Sandor T., Albert M., Stafford J., Kemper T.: Symmetrical and asymmetrical changes in brain tissue with age as measured on CT scans. Neurobiol. Aging 11: 21–27, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Stokely E.M., Sveindottir E., Lassen N.A., Rommer P.: A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. J. Comput. Assist. Tomogr. 4: 230–240, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Celsis P., Goldman T., Henriksen L., Lassen N.A.: A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J. Comput. Assist. Tomogr. 5: 641–645, 1981.

    Article  PubMed  CAS  Google Scholar 

  7. Kuhl D.E., Barrio J.R., Huang S.H., Selin C., Ackerman R.F., Lear J.L.: Quantifying local cerebral blood flow by N-isopropyl- (1231) iodoamphetamine (IMP) tomography. J. Nucl. Med. 23: 196–203, 1982.

    PubMed  CAS  Google Scholar 

  8. Hill T.C., Holman B.L., Lovett R., O’Leary D.H., Front D., Magistretti P., Zimmerman R.E., Moore S., Clouse M.E., Wu J.L., Lin T.H., Baldwin R.M.: Initial experience with SPECT (single photon computerized tomography) of the brain using n-isopropyl I-123 iodoamphetamine: concise report. J. Nucl. Med. 23: 191–195, 1982.

    PubMed  CAS  Google Scholar 

  9. Gemmel H.G., Sharp P.F., Evans N.T.S., Besson J.A.O., Lyall D., Smith F.W.: Single photon emission tomography with I-123 isopropylamphetamine in Alzheimer’s disease and multiinfarct dementia. Lancet II: 1348, 1984.

    Article  Google Scholar 

  10. Johnson K.A., Holman B.L., Rosen J., Nagel S., English R.J., Growdon J.H.: Iofetamine I-123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer’s disease. Arch. Intern. Med. 150: 752–756, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Neirinckx R.D., Canning L.R., Piper I.M., Nowotnik D.P., Pickett R.D., Holmes R.A., Volkert W.A., Forster A.M., Wesiner P.S., Marriott J.A., Chaplin S.B.: Technetium-99m d,l-HMPAO: a new radiopharmaceutical for SPECT imaging of regional perfusion. J. Nucl. Med. 28: 191–202, 1987.

    PubMed  CAS  Google Scholar 

  12. Andersen A.R., Friberg H.H., Schmidt J.F., Hasselbach S.G.: Quantitative measurements of cerebral blood flow using SPECT and (99mTc)-d,l-HMPAO compared to Xenon-133. J. Cereb. Blood Flow Metab. 8: S69–S81, 1988.

    Article  PubMed  CAS  Google Scholar 

  13. Waldemar G., Paulson O.B., Lassen N.A.: Brain imaging with SPECT in Alzheimer’s disease. In: Rapaport S.I., Petit H., Leys D., Christen Y. (Eds.), Imaging Cerebral Topography and Alzheimer’s Disease. Springer Verlag, Berlin, Heidelberg, 1990, pp. 139–144.

    Chapter  Google Scholar 

  14. Ingvar D.H., Risberg J.: Increase of regional blood flow during mental effort in normals and in patients with focal brain disorders. Exp. Brain Res. 3: 195–211, 1967.

    Article  PubMed  CAS  Google Scholar 

  15. Frackowiak R.S.J., Pozzilli C., Legg N.J., DuBoulay G.H., Marshall J., Lenzi G.L., Jones T.: Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104: 753–778, 1981.

    CAS  Google Scholar 

  16. Tikofsky R.S., Hellman R.S.: Brain single photon emission tomography: newer activation and intervention studies. Sem. Nucl. Med. 21: 40–57, 1991.

    Article  CAS  Google Scholar 

  17. Kety S.: Human cerebral blood flow and oxygen consumption as related to aging. J. Chronic Dis. 3: 478–486, 1956.

    Article  PubMed  CAS  Google Scholar 

  18. Melamed E., Lavy S., Bentin S., Cooper G., Rinto Y.: Reduction in cerebral blood flow during normal aging in man. Stroke 11: 31–35, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Shirahata N., Henriksen L., Vorstrup S., Holm S., Lauritzen M., Paulson O.B., Lassen N.A.: Regional cerebral blood flow assessed by Xenon-133 inhalation and emission tomography: normal values. J. Comput. Assist. Tomogr. 9: 861–866, 1985.

    Article  PubMed  CAS  Google Scholar 

  20. Pantano P., Baron J-C., Lebrun-Grandiè P., Duquesnoy N., Bousser M-G., Comar D.: Regional cerebral blood flow and oxygen consumption in human aging. Stroke 15: 635–641, 1984.

    Article  PubMed  CAS  Google Scholar 

  21. Dastur D.K.: Cerebral blood flow and metabolism in normal human aging, and senile dementia. J. Cereb. Blood Flow Metab. 5: 1–9, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Martin A.J., Friston K.J., Colebatch J.G., Frackowiak R.S.J.: Decreases of regional cerebral blood flow with normal aging. J. Cereb. Blood Flow Metab. 11: 684–689, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Waldemar G., Hasselbach S.G., Andersen A.R., Delecluse F., Petersen P., Johnsen A., Paulson O.B.: 99mTc-d,l-HMPAO and SPECT of the brain in normal aging. J. Cereb. Blood Flow Metab. 11: 508–521, 1991.

    Article  PubMed  CAS  Google Scholar 

  24. Creasey H., Rapaport S.I.: The aging human brain. Ann. Neurol. 17: 2–10, 1985.

    Article  PubMed  CAS  Google Scholar 

  25. Prigatano G.P.: Neuropsychology of aging. Compr. Ther. 13: 41–45, 1987.

    PubMed  CAS  Google Scholar 

  26. Frackowiak R.S.J.: Measurement and imaging of cerebral function in aging and dementia. Prog. Brain Res. 70: 69–85, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Kuhl D.E., Metter E.J., Riege W.H., Phelps M.E.: Effects of human aging on patterns of local cerebral glucose utilization determined by (18-F)-fluorodeoxyglucose method. J. Cereb. Blood Flow Metab. 2: 163–171, 1982.

    Article  PubMed  CAS  Google Scholar 

  28. Kuhl D.E., Metter E.J., Markham C.H.: Cerebral metabolism and atrophy in Huntington’s disease determined by 18-FDG and computed tomographic scan. Ann. Neurol. 12: 425–434, 1982.

    Article  PubMed  CAS  Google Scholar 

  29. Duara R., Grady C., Haxby J., Ingvar D., Sokoloff L., Margolin R.A., Manning R.G., Cutler N.R., Rapaport S.I.: Human brain glucose utilization and cognitive function in relation to age. Ann. Neurol. 16: 702–713, 1984.

    Article  CAS  Google Scholar 

  30. DeLeon M.J., George A.E., Ferris S.H., Christman D.R., Fowler J.S., Gentes C.I., Brodie J., Reisberg B., Wolf A.P.: Positron emission tomography and computed tomographic assessments of the aging human brain. J. Comput. Assist. Tomogr. 8: 88–94, 1984.

    Article  CAS  Google Scholar 

  31. Cohen M.B., Graham L.S., Lake R., Metter E.J., Fitten J., Kulkarni M.K., Sevrin R., Yamada L., Chang C.C., Woodruff N.: Diagnosis of Alzheimer’s disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. J. Nucl. Med. 27: 769–774, 1986.

    PubMed  CAS  Google Scholar 

  32. Sharp P., Gemmell H., Cherryman G., Besson J., Crawford J., Smith F.: Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. J. Nucl. Med. 27: 761–768, 1986.

    PubMed  CAS  Google Scholar 

  33. Smith F.W., Gemmell H.G., Sharp P.F.: The use of Tc-99m-HM-PAO for the diagnosis of dementia. Nucl. Med. Commun. 8: 525–533, 1987.

    Article  PubMed  CAS  Google Scholar 

  34. Jagust W.J., Budinger T.F., Reed B.R.: The diagnosis of dementia with single photon emission computed tomography. Arch. Neurol. 44: 258–262, 1987.

    Article  PubMed  CAS  Google Scholar 

  35. Neary D., Snowden J.S., Shields R.A., Burjan A.W.I., Northern B., MacDermott N., Prescott M.C., Testa H.J.: Single photon emission tomography using Tc-99m-HM-PAO in the investigation of dementia. J. Neurol. Neurosurg. Psychiatry 50: 1101–1109, 1987.

    Article  PubMed  CAS  Google Scholar 

  36. Johnson K.A., Mueller ST., Walshe T.M., English R.J., Holman B.L.: Cerebral perfusion imaging in Alzheimer’s disease: Use of single photon emission computed tomography and iofetamine hydrochloride I-123. Arch. Neurol. 44: 165–168, 1987.

    Article  PubMed  CAS  Google Scholar 

  37. Perani D., Di Piero V., Vallar G., Cappa S., Messa C., Bottini G., Berti A., Passafiume D., Scarlato G., Gerundini P., Lenzi G.L., Fazio F.: Technetium-99m HM- PAO-SPECT study of regional cerebral perfusion in early Alzheimer’s disease. J. Nucl. Med. 29: 1507–1514, 1988.

    PubMed  CAS  Google Scholar 

  38. Bonte F.J., Ross E.D., Chehabi H.H., Devous M.D.: SPECT study of regional cerebral blood flow in Alzheimer’s disease. J. Comput. Assist. Tomogr. 10: 579–583, 1986.

    Article  PubMed  CAS  Google Scholar 

  39. Testa H.J., Snowden J.S., Neary D., Shields R.A., Burjan A.W.L., Prescott M.C., Northern B., Goulding P.: The use of Tc-99m HM-PAO in the diagnosis of primary degenerative dementia. J. Cereb. Blood Flow Metab. 8: S123–S126, 1988.

    Article  PubMed  CAS  Google Scholar 

  40. Hellman R.S., Tikofsky R.S., Collier B.D., Hoffmann R.G., Plamer D.W., Glatt S.L., Antuono P.G., Isitman A.T., Papke R.A.: Alzheimer’s disease: Quantitative analysis of I-123 iodoamphetamine SPECT brain imaging. Radiology 172: 183–188, 1989.

    PubMed  CAS  Google Scholar 

  41. Deutsch G., Tweedy J.R.: Cerebral blood flow in severity-matched Alzheimer and multiinfarct patients. Neurology 37: 431–438, 1987.

    Article  PubMed  CAS  Google Scholar 

  42. Launes J., Sulkava R., Erkinjuntti T., Nikkinen P., Lindroth L., Liewendhal K., Livanainen M.: Tc-99m HMPAO SPECT in suspected dementia. Nucl Med. Commun. 12: 757–765, 1991.

    Article  PubMed  CAS  Google Scholar 

  43. Gemmel H.G., Sharp P.E., Besson J.A.O., Crawford J.R., Ebmeier K.P., Davidson J., Smith F.W.: Differential diagnosis in dementia using the cerebral blood flow agent 99mTc-HMPAO: a SPECT study. J. Comput. Assist. Tomogr. 11: 398–402, 1987.

    Article  Google Scholar 

  44. Costa D.C., Ell P.J., Burns A., Philpot M., Levy R.: CBF tomograms with (99mTc)-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson disease — initial results. J. Cereb. Blood Flow Metab. 8: S109–S115, 1988.

    Article  PubMed  CAS  Google Scholar 

  45. Pizzolato G., Dam M., Borsato N., Saitta B., DaCol C., Perlotto N., Zanco P., Ferlin G., Battistin L.: Tc-99m- HMPAO SPECT in Parkinson’s disease. J. Cereb. Blood Flow Metab. 8: S101–S108, 1988.

    Article  PubMed  CAS  Google Scholar 

  46. Nagel J.S., Ichise M., Holman B.L.: The scintigraphic evaluation of Huntington’s disease and other movement disorders using single photon emission computed tomography perfusion brain scans. Semin. Nucl. Med. 21: 11–23, 1991.

    Article  PubMed  CAS  Google Scholar 

  47. Grumwald F., Ziers S., Broich K., Schumacher S., Bockisch A., Biersack H.J.: HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). J. Nucl. Med. 31: 1740–1742, 1990.

    Google Scholar 

  48. Kuwabara Y., Ichiya Y., Otsuka M., Tahara T., Fukumura T., Gunasekera R., Masuda K.: Differential diagnosis of bilateral abnormalities in 123-I IMP SPECT imaging. Clin. Nucl. Med. 15: 893–899, 1990.

    Article  PubMed  CAS  Google Scholar 

  49. Haxby J.V., Grady C.L., Horvitz B., Shapiro M., Fried-land R.P., Rapaport S.I.: Heterogeneous anterior-posterior metabolic patterns in dementia of Alzheimer’s type. Neurology 38: 1853–1863, 1988.

    Article  PubMed  CAS  Google Scholar 

  50. Haxby J.V., Duara R., Grady C.L., Cutler N.R., Rapaport S.I.: Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer’s disease. J. Cereb. Blood Flow Metab. 6: 193–200, 1985.

    Article  Google Scholar 

  51. Celsis P., Agniel A., Puel M., Le Tinnier A., Viallard G., Demonet J-F., Rascol A., Marc-Vergnes J-P.: Lateral asymmetries in primary degenerative dementia of the Alzheimer type. A correlative study of cognitive, haemodynamic and EEG data, in relation with severity, age of onset and sex. Cortex 26: 585–596, 1990.

    CAS  Google Scholar 

  52. Celsis P., Agniel A., Puel M., Marc-Vergnes J-P.: Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J. Neurol. Neurosurg. Psychiatry 50: 1602–1612, 1987.

    Article  PubMed  CAS  Google Scholar 

  53. Haxby J.V.: Heterogeneous patterns of regional cerebral metabolism in Alzheimer’s disease: cross-sectional and longitudinal studies. In: Agnoli A., Cahn J., Lassen N., Mayeux R. (Eds.), Senile dementias. John Libbey Eurotext, Paris, 1988, pp. 65–72.

    Google Scholar 

  54. Holman B.L., Johnson K.A., Garada B., Carvalho P.A., Satlin A.: The scintigraphic appearance of Alzheimer’s disease: a prospective study using technetium-99m-HMPAO SPECT. J. Nucl. Med. 33: 181–185, 1992.

    PubMed  CAS  Google Scholar 

  55. Friedland R.P., Budinger T.F., Koss E., Ober B.A.: Alzheimer’s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett. 53: 235–240, 1985.

    Article  PubMed  CAS  Google Scholar 

  56. Benson D.F., Kuhl D.E., Hawkins R.A., Phelps M.E., Cummings J.L., Tsai S.Y.: The fluorodeoxyglucose (18-F) scan in Alzheimer’s disease and multi-infarct dementia. Arch. Neurol. 40: 711–714, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. Kuhl D.E., Metter E.J., Riege W.H.: Pattern of glucose cerebral utilization in depression, multiple infarct dementia, and Alzheimer’s disease. In: Sokoloff L. (Ed.), Brain imaging and brain function. Raven Press, New York, 1985, pp. 211–226.

    Google Scholar 

  58. Duara R., Grady C.L., Haxby J.V.: Positron emission tomography in Alzheimer’s disease. Neurology 36: 879–887, 1987.

    Article  Google Scholar 

  59. Holman B.L., Gibson R., Hill T., Eckelman W., Albert M., Reba R.: Muscarinic acetylcholine receptors in Alzheimer’s disease. JAMA 254: 3063–3066, 1985.

    Article  PubMed  CAS  Google Scholar 

  60. Burns A., Philpot M.P., Costa D.C., Ell P., Levy R.: The investigation of Alzheimer’s disease with single photon emission tomography. J. Neurol. Neurosurg. Psychiatry 52: 248–253, 1989.

    Article  PubMed  CAS  Google Scholar 

  61. Foster N.L., Chase T.N., Fedio P., Patronas N.J., Brooks R.A., DiChiro G.: Alzheimer’s disease: focal changes shown by positron emission tomography. Neurology 33: 961–965, 1983.

    Article  PubMed  CAS  Google Scholar 

  62. Cutler N.E., Haxby J.V., Duara R., Grady C.L., Kay A.D., Kessler R.M., Sundaram M., Rapaport S.I: Clinical history, brain metabolism and neuropsychological function in Alzheimer’s disease. Ann. Neurol. 18: 298–309, 1985.

    Article  PubMed  CAS  Google Scholar 

  63. Pelizzari C.A., Chen G.T.Y., Speibring D.R., Weichselbaum R.R., Chen C.T.: Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J. Comput. Assist. Tomogr. 13: 20–26, 1989.

    Article  PubMed  CAS  Google Scholar 

  64. Holman B.L., Zimmerman R.E., Johnson K.A., Carvalho P.A., Schwartz R.B., Loeffler J.S., Alexander E., Pelizzari A., Chen G.T.Y.: Computed-assisted super-imposition of Magnetic Resonance and high-resolution technetium-99m-HMPAO and Thallium-201 SPECT images of the brain. J. Nucl. Med. 32: 1478–1484, 1991.

    PubMed  CAS  Google Scholar 

  65. Friberg L., Roland P.E.: Functional activation and inhibition of regional cerebral blood flow and metabolism. In: Olesen J., Edvinsson L. (Eds.), Basic mechanism of headache. Elsevier Science Publ., Amsterdam, 1988, pp. 89–98.

    Google Scholar 

  66. Duara R., Barker W., Pascar S., Loewenstein L., Boothe T.: Behavioral activation PET studies in normal aging and Alzheimer’s disease (AD). J. Nucl. Med. 31: 730, 1990.

    Google Scholar 

  67. Battistin L., Pizzolato G., Dam M.: Single photon emission computed tomography studies with 99mTc- hexamethylpropyleneamine oxime in dementia: effects of acute administration of l-acetylcarnitine. Eur. Neurol. 29: 261–265, 1989.

    Article  PubMed  CAS  Google Scholar 

  68. Postiglione A., Soricelli A., Cicerano U., Mansi L., De Chiara S., Gallotta G., Schettini G., Salvatore M.: Effect of acute administration of l-acetyl-carnitine on cerebral blood flow in patients with chronic cerebral infarct. Pharmacol. Res. 23: 241–246, 1991.

    Article  PubMed  CAS  Google Scholar 

  69. Geaney D.P., Soper N., Shepstone B.J., Cowen P.J.: Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet 335: 1484–1487, 1990.

    Article  PubMed  CAS  Google Scholar 

  70. Klinkhammer P., Szelies B., Heiss W.D.: Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer’s disease. Dementia 1: 197–201, 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Internal Medicine and Metabolic Diseases, II Facoltà di Medicina e Chirurgia 2nd Medical School, University of Napoli, Via S. Pansini 5, 80131, Napoli, Italy

    Alfredo Postiglione (M.D.)

  2. Department of Nuclear Medicine/Clinical Physiology, Bispebjerg Hospital, Copenhagen, Denmark

    N. A. Lassen

  3. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussets, USA

    B. L. Holman

Authors
  1. Alfredo Postiglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. A. Lassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. L. Holman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Postiglione, A., Lassen, N.A. & Holman, B.L. Cerebral blood flow in patients with dementia of Alzheimer’s type. Aging Clin Exp Res 5, 19–26 (1993). https://doi.org/10.1007/BF03324122

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324122

En]Keywords

Search

Navigation